OCREVUS SOLUTION FOR INJECTION 920MG/23ML
Product details
Registration number: SIN17390P
Classification: Prescription Only
Active ingredients: Ocrelizumab
Strength: 920 mg/23 mL
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: L04AG08
HSA approval date: 11 November 2025
Manufacturer(s): Roche Diagnostics GmbH
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for OCREVUS SOLUTION FOR INJECTION 920MG/23ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17390P
Classification: Prescription Only
What active ingredients and strength are recorded for OCREVUS SOLUTION FOR INJECTION 920MG/23ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ocrelizumab
Strength: 920 mg/23 mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for OCREVUS SOLUTION FOR INJECTION 920MG/23ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for OCREVUS SOLUTION FOR INJECTION 920MG/23ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for OCREVUS SOLUTION FOR INJECTION 920MG/23ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Roche Diagnostics GmbH
Manufacturing country/countries: GERMANY
Where can I look up OCREVUS SOLUTION FOR INJECTION 920MG/23ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17390P or the exact product name OCREVUS SOLUTION FOR INJECTION 920MG/23ML. The general register link does not preselect this product.
What are the source dates for this OCREVUS SOLUTION FOR INJECTION 920MG/23ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this OCREVUS SOLUTION FOR INJECTION 920MG/23ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17390P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)